SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-16-014814
Filing Date
2016-11-14
Accepted
2016-11-14 07:03:11
Documents
74
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 764009
2 ex31-1.htm EX-31.1 19964
3 ex31-2.htm EX-31.2 20050
4 ex32-1.htm EX-32.1 8087
5 ex32-2.htm EX-32.2 8081
  Complete submission text file 0001493152-16-014814.txt   4154923

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20160930.xml EX-101.INS 712630
7 XBRL SCHEMA FILE aker-20160930.xsd EX-101.SCH 46982
8 XBRL CALCULATION FILE aker-20160930_cal.xml EX-101.CAL 62950
9 XBRL DEFINITION FILE aker-20160930_def.xml EX-101.DEF 171931
10 XBRL LABEL FILE aker-20160930_lab.xml EX-101.LAB 343027
11 XBRL PRESENTATION FILE aker-20160930_pre.xml EX-101.PRE 271129
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 161990397
SIC: 2835 In Vitro & In Vivo Diagnostic Substances